Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP430399.RAz0SNf96N6FjXKdXsE3lMsbhJQiZRde4BjnXPcS8-3PU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP430399.RAz0SNf96N6FjXKdXsE3lMsbhJQiZRde4BjnXPcS8-3PU130_assertion type Assertion NP430399.RAz0SNf96N6FjXKdXsE3lMsbhJQiZRde4BjnXPcS8-3PU130_head.
- NP430399.RAz0SNf96N6FjXKdXsE3lMsbhJQiZRde4BjnXPcS8-3PU130_assertion description "[Our findings underscore the existence of a molecular interplay between LKB1-AMPK-mTORC1 and ErbB2-AKT-mTORC2 pathways with mTOR at its epicenter, suggestive that loss of LKB1 expression may serve as a marker for hyperactivated mTOR in HER2 positive breast cancer and warranting further investigation into therapeutics that target LKB1-AMPK-mTOR and glycolytic pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP430399.RAz0SNf96N6FjXKdXsE3lMsbhJQiZRde4BjnXPcS8-3PU130_provenance.
- NP430399.RAz0SNf96N6FjXKdXsE3lMsbhJQiZRde4BjnXPcS8-3PU130_assertion evidence source_evidence_literature NP430399.RAz0SNf96N6FjXKdXsE3lMsbhJQiZRde4BjnXPcS8-3PU130_provenance.
- NP430399.RAz0SNf96N6FjXKdXsE3lMsbhJQiZRde4BjnXPcS8-3PU130_assertion SIO_000772 23451056 NP430399.RAz0SNf96N6FjXKdXsE3lMsbhJQiZRde4BjnXPcS8-3PU130_provenance.
- NP430399.RAz0SNf96N6FjXKdXsE3lMsbhJQiZRde4BjnXPcS8-3PU130_assertion wasDerivedFrom befree-20140225 NP430399.RAz0SNf96N6FjXKdXsE3lMsbhJQiZRde4BjnXPcS8-3PU130_provenance.
- NP430399.RAz0SNf96N6FjXKdXsE3lMsbhJQiZRde4BjnXPcS8-3PU130_assertion wasGeneratedBy ECO_0000203 NP430399.RAz0SNf96N6FjXKdXsE3lMsbhJQiZRde4BjnXPcS8-3PU130_provenance.